JULIA CAPUSON: Open Payments
NPI 1730820168 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 19 payments from 9 companies in 2025. Trend: 2023 $23 · 2024 $61 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $101 |
| Grifols USA, LLC | 3 | $74 |
| Merck Sharp & Dohme LLC | 2 | $61 |
| GENZYME CORPORATION | 2 | $53 |
| United Therapeutics Corporation | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Verona Pharma, Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: DUPIXENT, Prolastin-C Liquid, KEYTRUDA, Tyvaso, Ohtuvayre, YUPELRI, FASENRA, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
